Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834794 · ClinicalTrials.gov registry record · NA
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
A NA study of Cannabis Dependence, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 2
- Study locations
NCT01834794: Completed NA study of Cannabis Dependence, sponsored by Dartmouth-Hitchcock Medical Center.
NCT01834794 is a NA study of Cannabis Dependence that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 33 participants, below the 128-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834794, a NA study of Cannabis Dependence, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project aims to develop and test an intervention for the simultaneous treatment of cannabis use disorders and tobacco smoking. This is important because over 50% of adults seeking treatment to help stop cannabis use also smoke tobacco regularly, which decreases their chance for a successful treatment outcome and increases adverse acute and long-term psychosocial and health consequences. The proposed treatment will integrate existing computer-based behavioral interventions for cannabis and tobacco and use nicotine replacement medications to improve outcomes in this difficult to treat clinical population.
Primary Outcome
Sum of 24 hour quit attempts
Conditions Studied
Interventions
- BEHAVIORAL MET/CBT/CM plus NRT
Study Locations (2)
New Hampshire
- Geisel School of Medicine at Dartmouth; State Building Site - Concord
- Geisel School of Medicine at Dartmouth; Rivermill Complex Site - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01834794 record still lists
NCT01834794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 128-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Cannabis Dependence appearing as the primary indexed condition, and to 1 intervention - of which MET/CBT/CM plus NRT is the first listed.
NCT01834794 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT01834794 about?
NCT01834794 is a clinical study titled "Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders". This project aims to develop and test an intervention for the simultaneous treatment of cannabis use disorders and tobacco smoking. This is important because over 50% of adults seeking treatment to help stop cannabis use also smoke tobacco regularly, which decreases their chance for a successful tre...
What is the current status of trial NCT01834794?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2013-03. Estimated completion is 2015-01.
What conditions does trial NCT01834794 study?
This clinical trial studies the following conditions: Cannabis Dependence.
What interventions are being tested in trial NCT01834794?
The interventions under investigation include: MET/CBT/CM plus NRT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01834794?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01834794 being conducted?
This trial has 2 study locations across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01834794's enrollment target sits among peer trials
33 10th of 12 higher than 3 of 12 other Cannabis Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuroimaging of Adolescent Cannabis Use Treatment
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
-
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RECRUITING
-
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
COMPLETED · Phase 4
-
Treatment for Cannabis Withdrawal and Dependence
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia